Diagnostic Innovations in Glaucoma Study (DIGS)

This observational study, called the Diagnostic Innovations in Glaucoma Study (DIGS), aims to better understand how glaucoma (increased pressure inside the eye that can cause vision loss) affects vision and the structure of the back of the eye. Researchers are looking for the best ways to detect glaucoma and track its progression, especially in people with or without myopia (nearsightedness). They also want to see how glaucoma impacts daily life and quality of life. The study is open to adults aged 18 and older, including healthy individuals, those at risk for glaucoma, and those already diagnosed with glaucoma, with or without myopia. The goal is to improve how we manage glaucoma.

Study design
This is an observational study with a planned enrollment of 3000 participants. It is a longitudinal study, meaning participants are followed over time.
What's involved
Participants with or without myopia are typically examined about twice a year. Healthy controls with or without myopia are usually examined once.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00221897

Diagnostic Innovations in Glaucoma Study

Recruiting
Not specifiedAges 18+Observational
University of California, San Diego
~3,000 participants
Updated 2025-10-24 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring

A primary outcome measure isn't published for this study.

Primary Open Angle Glaucoma
Myopia
1 sites across 1 states
California1
  • Linda Zangwill, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Diego

Opens a ready-to-send draft in your own email app — review before sending.